targeting parasite fatty acyl-CoA synthetases

[1]  Inacio Mandomando,et al.  Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study , 2013, The Lancet.

[2]  R. Walzem,et al.  Palmitic acid in chicken granulosa cell death-lipotoxic mechanisms mediate reproductive inefficacy of broiler breeder hens. , 2012, Theriogenology.

[3]  C. Ge,et al.  The Mycobacterium tuberculosis very-long-chain fatty acyl-CoA synthetase: structural basis for housing lipid substrates longer than the enzyme. , 2012, Structure.

[4]  Christel Genoud,et al.  Acyl Coenzyme A Thioesterase Them5/Acot15 Is Involved in Cardiolipin Remodeling and Fatty Liver Development , 2012, Molecular and Cellular Biology.

[5]  TuKiet T. Lam,et al.  Endothelial Cell Palmitoylproteomic Identifies Novel Lipid-Modified Targets and Potential Substrates for Protein Acyl Transferases , 2012, Circulation research.

[6]  G. Zhu,et al.  Presence and removal of a contaminating NADH oxidation activity in recombinant maltose-binding protein fusion proteins expressed in Escherichia coli. , 2012, BioTechniques.

[7]  G. Zhu,et al.  Novel anti-Cryptosporidium activity of known drugs identified by high-throughput screening against parasite fatty acyl-CoA binding protein (ACBP). , 2012, The Journal of antimicrobial chemotherapy.

[8]  T. Tsuruo,et al.  Acyl‐CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide , 2009, Cancer science.

[9]  S. Ōmura,et al.  Anti-atherosclerotic Activity of Triacsin C, an Acyl-CoA Synthetase Inhibitor , 2008, The Journal of Antibiotics.

[10]  G. Zhu,et al.  Functional characterization of the acyl-[acyl carrier protein] ligase in the Cryptosporidium parvum giant polyketide synthase. , 2007, International journal for parasitology.

[11]  S. Yamaguchi,et al.  Long-chain fatty acids induce lipid droplet formation in a cultured human hepatocyte in a manner dependent of Acyl-CoA synthetase. , 2006, Biological & pharmaceutical bulletin.

[12]  S. J. Upton,et al.  Application of Quantitative Real-Time Reverse Transcription-PCR in Assessing Drug Efficacy against the Intracellular Pathogen Cryptosporidium parvum In Vitro , 2005, Antimicrobial Agents and Chemotherapy.

[13]  Shuli Wang,et al.  Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: identification of a novel variant of isoform 6. , 2005, Biochemistry.

[14]  Ping Xu,et al.  Complete Genome Sequence of the Apicomplexan, Cryptosporidium parvum , 2004, Science.

[15]  Lihua Xiao,et al.  Characterization of a Cryptosporidium parvum Gene Encoding a Protein with Homology to Long Chain Fatty Acid Synthetase , 2003, The Journal of eukaryotic microbiology.

[16]  P. Black,et al.  Vectorial Acylation in Saccharomyces cerevisiae , 2003, The Journal of Biological Chemistry.

[17]  J. Mead,et al.  Susceptibility to Cryptosporidium parvum Infections in Cytokine- and Chemokine-Receptor Knockout Mice , 2002, The Journal of parasitology.

[18]  P. Black,et al.  Functional Role of Fatty Acyl-Coenzyme A Synthetase in the Transmembrane Movement and Activation of Exogenous Long-chain Fatty Acids , 2002, The Journal of Biological Chemistry.

[19]  T. M. Lewin,et al.  Expression and Characterization of Recombinant Rat Acyl-CoA Synthetases 1, 4, and 5 , 2001, The Journal of Biological Chemistry.

[20]  A. Alcina,et al.  The cloning and expression of Pfacs1, a Plasmodium falciparum fatty acyl coenzyme A synthetase-1 targeted to the host erythrocyte cytoplasm. , 1999, Journal of molecular biology.

[21]  S. Tzipori,et al.  Efficacy of Nitazoxanide againstCryptosporidium parvum in Cell Culture and in Animal Models , 1998, Antimicrobial Agents and Chemotherapy.

[22]  R. Coleman,et al.  Triacsin C blocks de novo synthesis of glycerolipids and cholesterol esters but not recycling of fatty acid into phospholipid: evidence for functionally separate pools of acyl-CoA. , 1997, The Biochemical journal.

[23]  N. Færgeman,et al.  Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. , 1997, The Biochemical journal.

[24]  K. Donaldson,et al.  Improved Purification Methods for Calf‐Derived Cryptosporidium parvum Oocysts Using Discontinuous Sucrose and Cesium Chloride Gradients , 1996, The Journal of eukaryotic microbiology.

[25]  Tokuo T. Yamamoto,et al.  Molecular Characterization and Expression of Rat Acyl-CoA Synthetase 3* , 1996, The Journal of Biological Chemistry.

[26]  M. Arrowood,et al.  A new method for evaluating experimental cryptosporidial parasite loads using immunofluorescent flow cytometry. , 1995, The Journal of parasitology.

[27]  B. Corkey,et al.  Long chain acyl coenzyme A and signaling in neutrophils. An inhibitor of acyl coenzyme A synthetase, triacsin C, inhibits superoxide anion generation and degranulation by human neutrophils. , 1994, The Journal of biological chemistry.

[28]  M. Resh,et al.  Regulation of enzymatic activity by active site fatty acylation. A new role for long chain fatty acid acylation of proteins. , 1994, The Journal of biological chemistry.

[29]  K. Ichihara,et al.  An enzyme-coupled assay for acyl-CoA synthetase. , 1991, Journal of lipid research.

[30]  S Omura,et al.  Evidence for an essential role of long chain acyl-CoA synthetase in animal cell proliferation. Inhibition of long chain acyl-CoA synthetase by triacsins caused inhibition of Raji cell proliferation. , 1991, The Journal of biological chemistry.

[31]  S. Ōmura,et al.  Triacsin C: a differential inhibitor of arachidonoyl-CoA synthetase and nonspecific long chain acyl-CoA synthetase. , 1989, Prostaglandins.

[32]  H. Vial,et al.  Acyl-CoA synthetase activity in Plasmodium knowlesi-infected erythrocytes displays peculiar substrate specificities. , 1988, Biochimica et biophysica acta.

[33]  Tomoda Hiroshi,et al.  Inhibition of acyl-CoA synthetase by triacsins. , 1987 .

[34]  C. Sterling,et al.  Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients. , 1987, The Journal of parasitology.

[35]  J. Rothman,et al.  Possible role for fatty acyl-coenzyme A in intracellular protein transport , 1987, Nature.

[36]  S. Ōmura,et al.  Triacsins, new inhibitors of acyl-CoA synthetase produced by Streptomyces sp. , 1986, The Journal of antibiotics.

[37]  H. Imanaka,et al.  Studies on new vasodilators, WS-1228 A and B. II. Structure and synthesis. , 1982, Journal of antibiotics (Tokyo. 1968).

[38]  H. Imanaka,et al.  Studies on new vasodilators, WS-1228 A and B. I. Discovery, taxonomy, isolation and characterization. , 1982, The Journal of antibiotics.

[39]  S. Bernson.  Acetyl-CoA hydrolase; activity, regulation and physiological significance of the enzyme in brown adipose tissue from hamster. , 1976, European journal of biochemistry.

[40]  S. D. Rider,et al.  Cryptosporidium: genomic and biochemical features. , 2010, Experimental parasitology.

[41]  R. Warren,et al.  Characterization of triacsin C inhibition of short‐, medium‐, and long‐chain fatty acid:CoA ligases of human liver , 2004, Journal of biochemical and molecular toxicology.

[42]  A. Alcina,et al.  The Plasmodium falciparum fatty acyl-CoA synthetase family (PfACS) and differential stage-specific expression in infected erythrocytes. , 2003, Molecular and biochemical parasitology.